Almac Diagnostics' New Biopharma Biomarker Program Will Include Arrays, qPCR

Almac has offered its experience, particularly with array technology, to pharma partners in the past, but the new program represents a single, comprehensive package specifically for pre-clinical drug development.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.